Release of Tissue-Type Plasminogen Activator in Response to Muscarinic Receptor Stimulation in Human Forearm

Summary

We have recently shown that mental stress increases local net release of tissue-type plasminogen activator (t-PA) across the forearm vascular bed. However, the mechanisms responsible for the t-PA release in man during stress are undefined. To study the effects of endothelial cell receptor stimulation and fluid shear stress we used the perfused forearm model to characterize the in vivo tissue plasminogen activator (t-PA) response in man to methacholine (Mch) and sodium nitroprus-side (SNP), at doses calculated to cause similar degrees of vasodilation. The study was performed in 7 healthy young men (age 22-24 yrs) without hypertension, diabetes mellitus, or hypercholesterolemia. Each subject received double-blind step-wise i. a. infusions of Mch (0.1-0.8-4.0 μg/min) and SNP (0.5-2.5-10 μg/min) in randomized order. Each dose step was infused for 5 min. Forearm blood flow was assessed by plethysmography. Net release/uptake was expressed as the product of arterio-venous concentration gradient and forearm plasma flow. At pre-infusion baseline, there was a significant net release of t-PA antigen of approximately 0.9 ng × min⁻¹ × 100 ml⁻¹ and t-PA activity of 3.5 fmol × min⁻¹ × 100 ml⁻¹ across the forearm. I. a. infusion of Mch and SNP increased forearm blood flow from 1.9 to 14.9 and from 1.8 to 12.1 ml × min⁻¹ × 100 mb1, respectively (Mch vs SBP N. S.). Net release of t-PA antigen increased more than 10-fold from 0.9 to 10.7 ng × min⁻¹ × 100 ml⁻¹ after Mch, but fell after SNP (2-way . ANOVA, Mch vs SNP p = 0.05). t-PA activity net release increased from 4.0 to 100 fmol × min⁻¹ × 100 ml⁻¹ after Mch, but switched to a net uptake after SNP (Mch vs SNP p = 0.02). No consistent changes of PAI⁻¹ antigen were observed during either infusion. It is concluded, that endothelial muscarinic receptor stimulation causes a marked increase in net release of t-PA antigen and activity, in conjunction with endothelium-dependent vasodilation. By contrast, increased fluid shear stress per se by receptor-independent vasodilation has little effect on t-PA release.

• References

• 01 Jem C, Eriksson E, Tengborn L, Risberg B, Wadenvik H, Jem S. Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost 1989; 62: 767-771
• 2 Jern C, Manhem K, Eriksson E, Tengborn L, Risberg B, Jern S. Hemostatic responses to mental stress during the menstrual cycle. Thromb Haemost 1991; 66: 614-618
• 3 Jem C, Selin L, Jem S. In vivo release of tissue-type plasminogen activator across the human forearm during mental stress. Thromb Haemost 1994 in press
• 4 Jern S. Effects of acute carbohydrate administration on central hemodynamics and circulatory responses to mental stress. Hypertension 1991; 18: 790-797
• 5 Emeis JJ. Regulation of the acute release of tissue-type plasminogen activator from endothelium by coaglation products. In: Plasminogen activation in fibrinolysis in tissue remodelling, and in development Brakman P, Kluft C. eds Annals of the New York Academy of Sciences; 1992. 66 249-258
• 6 Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 334: 997-1000
• 7 Panza JA, Quyyumi AA, Brush JJ, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1190; 323: 22-27
• 08 Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992; 90: 2548-2554
• 9 Klöcking H-P. Release of plasminogen activator by acetylcholine from the isolated perfused pig ear. Thromb Res 1979; 16: 261-264
• 10 Nakajima K. Pharmacological observations of plasminogen activator release caused by vasoactive agents in isolated perfused pig ears. Thromb Res 1983; 29: 163-174
• 11 Emeis JJ. Perfused rat hindlegs. A model to study plasminogen activator release. Thromb Res 1983; 30: 195-203
• 12 Jern S. Psychological and hemodynamic factors in borderline hypertension. Acta Med Scand 1982; Suppl 662: 1-54
• 13 Petersen LC, Handest P, Brender J, Selmer J, Jørgensen M, Thorsen S. A sensitive solid-phase immunosorbent assay for tissue-type plasminogen activator activity in plasma using trinitrobenzoylated poly-D-lysin as a stimulator for plasminogen activation. Thromb Haemost 1987; 57: 205-211
• 14 Rånby M, Nguyen G, Scarabin PY, Samama M. Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Thromb Haemost 1989; 61: 409-414
• 15 Huisman LGM, Meijer P, van Griensven J, Luft C. Evaluation of the specificity of antigen assays for plasminogen activator inhibitor 1: comparison of two new commercial kits. Fibrinolysis 1992; 6 (Suppl. 03) 87-88
• 16 Vasey MW, Thayer JF. The continuing problem of false positives in repeated measures ANOVA in psychophysiology: A multivariate solution. Psychophysiology 1987; 24: 479-486
• 17 Jem S. Effects of insulin on vascular responses to mental stress and norepinephrine in human forearm. Submitted for publication 1994
• 18 Diamond SL, Eskin SG, Mclntire LV. Fluid flow stimulates tissue plasminogen secretion by cultured human endothelial cells. Science 1989; 243: 1483-1485
• 19 Diamond SL, Sharefkin JB, Dieffenbach C, Fraiser-Scott K, Mclntire LV, Eskin SG. Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress. J Cell Physiol 1990; 143: 364-371
• 20 Holeman R, Johnston JG, Reddick RL. Release of plasminogen activator by the perfused dog kidney. Nature 1965; 208: 291-292
• 21 Tranquille N, Emeis JJ. The involvement of products of the phospholipase pathway in the acute release of tissue-type plasminogen activator. Eur J Pharmacol 1992; 213: 285-292
• 22 Nollert MU, Eskin SG, Mclntire LV. Shear stress increases inositol tris-phosphate levels in human endothelial cells. Biochem Biophys Res Com 1990; 170: 281-287
• 23 Rosing DR, Redwood DR, Brakman P, Astrup T, Epstein SE. The fibrinolytic response of man to vasoactive drugs measured in arterial blood. Thromb Res 1978; 13: 419-428
• 24 Lidbury PS, Korbut R, Vane JR. Sodium nitroprusside modulates the fibrinolytic system in the rabbit. Br J Pharmacol 1990; 101: 527-530
• 25 Mehta JL, Nicolini FA, Nichols WW, Saldeen TGP. Concurrent nitroglycerin administration decreases thrombolytic potential of tissue-type plasminogen activator. JACC 1991; 17: 805-811
• 26 Emeis JeJ. Mechanisms involved in short-term changes in blood levels of tissue-type plasminogen activator. In: Tissue-type Plasminogen Activator (t-PA): Physiological and Clinical Aspects Kluft C. ed CRC Press; Boca Raton FL: 1988. 2 21-35
• 27 Izaki S, Kitaguchi H. Calcium dependent and independent release of plasminogen activator from the vascular wall. Thromb Res 1977; 10: 765-770
• 28 Prowse CV, MacGregor IR. Regulation of the plasminogen activator level in blood. In: Tissue-type Plasminogen Activator (t-PA), Physiological and Clinical Aspects Kluft C. ed CRC Press; Boca Raton FL: 1988. 2 49-66
• 29 Lambert TL, Kent TS, Whorton AR. Bradikinin stimulation of inositol polyphosphate production in porcine aortic endothelial cells. J Biol Chem 1986; 261: 15288-15293
• 30 Pollock KW, Wreggett KA, Irvine RF. Inositol phosphate production and Ca²⁺ mobilization in human umbilical-vein endothelial cells stimulated by thrombin and histamine. Biochem J 1988; 256: 371-376
• 31 Lampugnani MG, Pedenovi M, Dejana E, Rotilio D, Donati MB, Bussolino F, Garbarino Get al. Human α-thrombin induces phosphinositide turnover and Ca²⁺ movements in cultured human umbilical vein endothelial cells. Thromb Res 1989; 54: 75-87
• 32 Kruithof EKO. Plasminogen activator inhibitor type 1: Biochemical, biological and clinical aspects. Fibrinolysis 1988; 2 (Suppl. 02) 59-70
• 33 Loskutoff DJ, Sawdey M, Keeton M, Schneiderman J. Regulation of PAI-1 gene expression in vivo. Thromb Haemost 1993; 70: 135-137